Andrew Elzinga of Cornerstone Research and Aviv Nevo of the University of Pennsylvania will join partners from Goodwin Proctor to examine emerging antitrust trends in the life sciences.
This webinar will pair legal and economic perspectives with practical, actionable guidance to help life sciences companies anticipate challenges, assess risk, and stay ahead of the curve in a rapidly evolving antitrust landscape.
Panelists will discuss class action and life sciences antitrust litigation involving:
- Pharmacy benefit manager (PBM) contracting and rebate structures
- Exclusive dealing and foreclosure theories
- Medicare and 340B program dynamics
- Biosimilar competition and lifecycle management strategies
This event is cohosted by Cornerstone Research and Goodwin Proctor. For more information, visit the event website.
Boston 
